Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy

Adaikalakoteswari, A and Balasubramanyam, M and Ravikumar, R and Deepa, R and Mohan, V (2007) Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis, 195 (1). pp. 83-9. ISSN 00219150

Restricted to MDRF users only. Others may ->



Objective: Shortening of telomere length has been reported in several conditions including Type 2 diabetes and atherosclerosis. The aims of this study were (1) to assess whether telomere shortening occurs at the stage of pre-diabetes, i.e., impaired glucose tolerance (IGT) and (2) whether telomere shortening was greater in Type 2 diabetic subjects with atherosclerotic plaques. Methods: Subjects with impaired glucose tolerance (IGT) (n = 30), non-diabetic control subjects (n = 30), Type 2 diabetic patients without (n = 30) and with atherosclerotic plaques (n = 30) were selected from the Chennai Urban Rural Epidemiology Study (CURES), an ongoing epidemiological population-based study. Southern-blot analysis was used to determine mean terminal restriction fragment (TRF) length, a measure of average telomere size, in leukocyte DNA. Levels of thiobarbituric acid reactive substances (TBARS), protein carbonyl content (PCO) and high sensitive C-reactive protein (hs-CRP) were measured by standard methodologies. Carotid intima-media thickness (IMT) was assessed by high resolution B-mode ultrasonography. Results: The mean (±S.E.) TRF lengths were significantly lower in IGT subjects (6.97±0.3 kb; p = 0.002) and lower still in Type 2 diabetic subjects without plaques (6.21±0.2; p = 0.0001) and lowest in Type 2 diabetic subjects with atherosclerotic plaques (5.39±0.2; p = 0.0001) when compared to control subjects (8.7±0.5). In IGT subjects, TRF length was positively correlated to HDL cholesterol and negatively correlated to glycated hemoglobin (HbA1c), TBARS, PCO, HOMA-IR and IMT. In multiple linear regression analysis, presence of diabetes, HDL cholesterol and increased TBARS levels appear as significant determinants of telomere shortening. Conclusion: Telomere shortening is seen even at the stage of IGT. Among subjects with Type 2 diabetes, those with atherosclerotic plaques had greater shortening of telomere length compared to those without plaques.

Item Type:Article
Official URL/DOI:
Uncontrolled Keywords:Oxidative stress; Telomere shortening; Macroangiopathy; IGT
Subjects:Biochemistry,Cell and Molecular Signalling > Cell Signalling-Diabetes
Diabetes > CURES
Divisions:Department of Cell and Molecular Biology
Department of Diabetology
ID Code:99
Deposited On:24 Oct 2009 09:40
Last Modified:24 Oct 2009 09:40

Repository Staff Only: item control page